Low lipolytic enzyme activity in patients with severe hypertriglyceridemia on highly active antiretroviral therapy
Authors:
- Laurence BarilLBLaurence Baril
- Isabel BeuclerIBIsabel Beucler
- Marc-Antoine ValantinMVMarc-Antoine Valantin
- Eric BruckertEBEric Bruckert
- Dominique Bonnefont-RousselotDBDominique Bonnefont-Rousselot
- Anne CoutellierACAnne Coutellier
- Eric CaumesECEric Caumes
- Christine KatlamaCKChristine Katlama
- François BricaireFBFrançois Bricaire
- 1 February 2001
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (3) , 415-417
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Effects of Protease Inhibitors on Hyperglycemia, Hyperlipidemia, and LipodystrophyArchives of internal medicine (1960), 2000
- Effect of ritonavir on lipids and post-heparin lipase activities in normal subjectsAIDS, 2000
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Changes in AIDS incidence for men who have sex with men, United States 1990–1995AIDS, 1997
- Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings.Journal of Lipid Research, 1983
- Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.Journal of Lipid Research, 1981